nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—Alkylating Activity—Estramustine—prostate cancer	0.334	1	CiPCiCtD
Ifosfamide—testicular cancer—prostate cancer	0.239	1	CtDrD
Ifosfamide—CYP2C18—prostate cancer	0.0546	0.33	CbGaD
Ifosfamide—CYP3A5—prostate cancer	0.036	0.217	CbGaD
Ifosfamide—CYP2A6—prostate cancer	0.0348	0.21	CbGaD
Ifosfamide—CYP2C19—prostate cancer	0.0245	0.148	CbGaD
Ifosfamide—CYP3A4—prostate cancer	0.0156	0.0941	CbGaD
Ifosfamide—CYP2C8—Nilutamide—prostate cancer	0.00839	0.0524	CbGbCtD
Ifosfamide—CYP3A5—Flutamide—prostate cancer	0.00723	0.0451	CbGbCtD
Ifosfamide—CYP2C19—Bicalutamide—prostate cancer	0.00704	0.0439	CbGbCtD
Ifosfamide—CYP2C19—Nilutamide—prostate cancer	0.00704	0.0439	CbGbCtD
Ifosfamide—CYP2C8—Abiraterone—prostate cancer	0.00695	0.0434	CbGbCtD
Ifosfamide—CYP2B6—Estrone—prostate cancer	0.00664	0.0414	CbGbCtD
Ifosfamide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00648	0.0404	CbGbCtD
Ifosfamide—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00591	0.0369	CbGbCtD
Ifosfamide—CYP2C9—Bicalutamide—prostate cancer	0.00585	0.0365	CbGbCtD
Ifosfamide—CYP2C9—Nilutamide—prostate cancer	0.00585	0.0365	CbGbCtD
Ifosfamide—CYP2C19—Flutamide—prostate cancer	0.00583	0.0364	CbGbCtD
Ifosfamide—CYP3A5—Cabazitaxel—prostate cancer	0.00535	0.0334	CbGbCtD
Ifosfamide—CYP3A5—Estrone—prostate cancer	0.00523	0.0326	CbGbCtD
Ifosfamide—CYP2C8—Cabazitaxel—prostate cancer	0.00514	0.0321	CbGbCtD
Ifosfamide—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00448	0.028	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.004	0.025	CbGbCtD
Ifosfamide—CYP3A7—Estradiol—prostate cancer	0.004	0.025	CbGbCtD
Ifosfamide—CYP2C9—Estrone—prostate cancer	0.00351	0.0219	CbGbCtD
Ifosfamide—CYP3A4—Bicalutamide—prostate cancer	0.0034	0.0212	CbGbCtD
Ifosfamide—PTGS1—Etoposide—prostate cancer	0.00327	0.0204	CbGbCtD
Ifosfamide—CYP3A4—Estramustine—prostate cancer	0.00316	0.0197	CbGbCtD
Ifosfamide—CYP3A5—Estradiol—prostate cancer	0.003	0.0187	CbGbCtD
Ifosfamide—CYP2C8—Estradiol—prostate cancer	0.00289	0.018	CbGbCtD
Ifosfamide—CYP3A4—Flutamide—prostate cancer	0.00282	0.0176	CbGbCtD
Ifosfamide—CYP3A4—Abiraterone—prostate cancer	0.00282	0.0176	CbGbCtD
Ifosfamide—CYP2C9—Capecitabine—prostate cancer	0.00266	0.0166	CbGbCtD
Ifosfamide—CYP2C19—Estradiol—prostate cancer	0.00242	0.0151	CbGbCtD
Ifosfamide—CYP3A7—Docetaxel—prostate cancer	0.00239	0.0149	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00239	0.0149	CbGbCtD
Ifosfamide—CYP3A4—Cabazitaxel—prostate cancer	0.00209	0.013	CbGbCtD
Ifosfamide—CYP2C19—Prednisone—prostate cancer	0.00208	0.013	CbGbCtD
Ifosfamide—CYP3A4—Estrone—prostate cancer	0.00204	0.0127	CbGbCtD
Ifosfamide—CYP2C9—Estradiol—prostate cancer	0.00201	0.0126	CbGbCtD
Ifosfamide—CYP3A5—Etoposide—prostate cancer	0.00196	0.0122	CbGbCtD
Ifosfamide—CYP2C8—Etoposide—prostate cancer	0.00188	0.0118	CbGbCtD
Ifosfamide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00182	0.0113	CbGbCtD
Ifosfamide—CYP3A5—Docetaxel—prostate cancer	0.00179	0.0112	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—prostate cancer	0.0017	0.0106	CbGbCtD
Ifosfamide—CYP3A4—Conjugated Estrogens—prostate cancer	0.00133	0.00832	CbGbCtD
Ifosfamide—CYP3A4—Mitoxantrone—prostate cancer	0.00121	0.00756	CbGbCtD
Ifosfamide—CYP3A4—Estradiol—prostate cancer	0.00117	0.00731	CbGbCtD
Ifosfamide—CYP3A4—Prednisone—prostate cancer	0.00101	0.00628	CbGbCtD
Ifosfamide—CYP3A4—Etoposide—prostate cancer	0.000764	0.00477	CbGbCtD
Ifosfamide—CYP3A4—Docetaxel—prostate cancer	0.000699	0.00436	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—prostate cancer	0.000521	0.00325	CbGbCtD
Ifosfamide—Cyclophosphamide—CYP2C18—prostate cancer	0.000431	0.33	CrCbGaD
Ifosfamide—Cyclophosphamide—CYP3A5—prostate cancer	0.000284	0.217	CrCbGaD
Ifosfamide—Cyclophosphamide—CYP2A6—prostate cancer	0.000275	0.21	CrCbGaD
Ifosfamide—CYP2C19—urine—prostate cancer	0.000222	0.175	CbGeAlD
Ifosfamide—Cyclophosphamide—CYP2C19—prostate cancer	0.000193	0.148	CrCbGaD
Ifosfamide—CYP2C9—urine—prostate cancer	0.000172	0.136	CbGeAlD
Ifosfamide—CYP3A4—urine—prostate cancer	0.000131	0.104	CbGeAlD
Ifosfamide—CYP2A6—prostate gland—prostate cancer	0.000124	0.0978	CbGeAlD
Ifosfamide—Cyclophosphamide—CYP3A4—prostate cancer	0.000123	0.0941	CrCbGaD
Ifosfamide—CYP2A6—seminal vesicle—prostate cancer	0.000105	0.0828	CbGeAlD
Ifosfamide—CYP3A5—prostate gland—prostate cancer	6.27e-05	0.0496	CbGeAlD
Ifosfamide—PTGS1—prostate gland—prostate cancer	5.63e-05	0.0445	CbGeAlD
Ifosfamide—PTGS1—seminal vesicle—prostate cancer	4.76e-05	0.0377	CbGeAlD
Ifosfamide—CYP2C8—renal system—prostate cancer	4.73e-05	0.0374	CbGeAlD
Ifosfamide—CYP3A5—renal system—prostate cancer	4.27e-05	0.0338	CbGeAlD
Ifosfamide—CYP2B6—renal system—prostate cancer	4.25e-05	0.0336	CbGeAlD
Ifosfamide—PTGS1—epithelium—prostate cancer	4.14e-05	0.0327	CbGeAlD
Ifosfamide—PTGS1—renal system—prostate cancer	3.84e-05	0.0304	CbGeAlD
Ifosfamide—CYP3A4—renal system—prostate cancer	3.21e-05	0.0254	CbGeAlD
Ifosfamide—CYP2C8—testis—prostate cancer	3.06e-05	0.0242	CbGeAlD
Ifosfamide—CYP2B6—testis—prostate cancer	2.74e-05	0.0217	CbGeAlD
Ifosfamide—PTGS1—testis—prostate cancer	2.48e-05	0.0196	CbGeAlD
Ifosfamide—PTGS1—lymph node—prostate cancer	1.8e-05	0.0142	CbGeAlD
Ifosfamide—Neuropathy peripheral—Doxorubicin—prostate cancer	9.69e-06	0.000159	CcSEcCtD
Ifosfamide—Urticaria—Etoposide—prostate cancer	9.65e-06	0.000158	CcSEcCtD
Ifosfamide—Haemoglobin—Epirubicin—prostate cancer	9.63e-06	0.000158	CcSEcCtD
Ifosfamide—Stomatitis—Doxorubicin—prostate cancer	9.63e-06	0.000158	CcSEcCtD
Ifosfamide—Anorexia—Docetaxel—prostate cancer	9.62e-06	0.000158	CcSEcCtD
Ifosfamide—Malaise—Prednisone—prostate cancer	9.62e-06	0.000158	CcSEcCtD
Ifosfamide—Body temperature increased—Etoposide—prostate cancer	9.6e-06	0.000158	CcSEcCtD
Ifosfamide—Abdominal pain—Etoposide—prostate cancer	9.6e-06	0.000158	CcSEcCtD
Ifosfamide—Conjunctivitis—Doxorubicin—prostate cancer	9.6e-06	0.000158	CcSEcCtD
Ifosfamide—Nervous system disorder—Capecitabine—prostate cancer	9.59e-06	0.000157	CcSEcCtD
Ifosfamide—Vertigo—Prednisone—prostate cancer	9.59e-06	0.000157	CcSEcCtD
Ifosfamide—Haemorrhage—Epirubicin—prostate cancer	9.59e-06	0.000157	CcSEcCtD
Ifosfamide—Hepatitis—Epirubicin—prostate cancer	9.59e-06	0.000157	CcSEcCtD
Ifosfamide—Thrombocytopenia—Capecitabine—prostate cancer	9.57e-06	0.000157	CcSEcCtD
Ifosfamide—Skin disorder—Capecitabine—prostate cancer	9.5e-06	0.000156	CcSEcCtD
Ifosfamide—Urinary tract disorder—Epirubicin—prostate cancer	9.47e-06	0.000155	CcSEcCtD
Ifosfamide—Hyperhidrosis—Capecitabine—prostate cancer	9.45e-06	0.000155	CcSEcCtD
Ifosfamide—Hypotension—Docetaxel—prostate cancer	9.44e-06	0.000155	CcSEcCtD
Ifosfamide—Haematuria—Doxorubicin—prostate cancer	9.42e-06	0.000155	CcSEcCtD
Ifosfamide—Connective tissue disorder—Epirubicin—prostate cancer	9.42e-06	0.000155	CcSEcCtD
Ifosfamide—Urethral disorder—Epirubicin—prostate cancer	9.4e-06	0.000154	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Doxorubicin—prostate cancer	9.34e-06	0.000153	CcSEcCtD
Ifosfamide—Anorexia—Capecitabine—prostate cancer	9.32e-06	0.000153	CcSEcCtD
Ifosfamide—Nausea—Estradiol—prostate cancer	9.31e-06	0.000153	CcSEcCtD
Ifosfamide—Vomiting—Mitoxantrone—prostate cancer	9.29e-06	0.000152	CcSEcCtD
Ifosfamide—Convulsion—Prednisone—prostate cancer	9.24e-06	0.000152	CcSEcCtD
Ifosfamide—Visual impairment—Epirubicin—prostate cancer	9.24e-06	0.000152	CcSEcCtD
Ifosfamide—Agranulocytosis—Doxorubicin—prostate cancer	9.22e-06	0.000151	CcSEcCtD
Ifosfamide—Hypertension—Prednisone—prostate cancer	9.21e-06	0.000151	CcSEcCtD
Ifosfamide—Rash—Mitoxantrone—prostate cancer	9.21e-06	0.000151	CcSEcCtD
Ifosfamide—Dermatitis—Mitoxantrone—prostate cancer	9.2e-06	0.000151	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.2e-06	0.000151	CcSEcCtD
Ifosfamide—Hypotension—Capecitabine—prostate cancer	9.14e-06	0.00015	CcSEcCtD
Ifosfamide—Myalgia—Prednisone—prostate cancer	9.08e-06	0.000149	CcSEcCtD
Ifosfamide—Arthralgia—Prednisone—prostate cancer	9.08e-06	0.000149	CcSEcCtD
Ifosfamide—Paraesthesia—Docetaxel—prostate cancer	9.07e-06	0.000149	CcSEcCtD
Ifosfamide—Erythema multiforme—Epirubicin—prostate cancer	9.06e-06	0.000149	CcSEcCtD
Ifosfamide—Bradycardia—Doxorubicin—prostate cancer	9.03e-06	0.000148	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	9.02e-06	0.000148	CcSEcCtD
Ifosfamide—Dyspnoea—Docetaxel—prostate cancer	9e-06	0.000148	CcSEcCtD
Ifosfamide—Somnolence—Docetaxel—prostate cancer	8.98e-06	0.000147	CcSEcCtD
Ifosfamide—Discomfort—Prednisone—prostate cancer	8.97e-06	0.000147	CcSEcCtD
Ifosfamide—Eye disorder—Epirubicin—prostate cancer	8.96e-06	0.000147	CcSEcCtD
Ifosfamide—Hypersensitivity—Etoposide—prostate cancer	8.95e-06	0.000147	CcSEcCtD
Ifosfamide—Tinnitus—Epirubicin—prostate cancer	8.94e-06	0.000147	CcSEcCtD
Ifosfamide—Haemoglobin—Doxorubicin—prostate cancer	8.91e-06	0.000146	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.91e-06	0.000146	CcSEcCtD
Ifosfamide—Cardiac disorder—Epirubicin—prostate cancer	8.9e-06	0.000146	CcSEcCtD
Ifosfamide—Flushing—Epirubicin—prostate cancer	8.9e-06	0.000146	CcSEcCtD
Ifosfamide—Haemorrhage—Doxorubicin—prostate cancer	8.87e-06	0.000146	CcSEcCtD
Ifosfamide—Hepatitis—Doxorubicin—prostate cancer	8.87e-06	0.000146	CcSEcCtD
Ifosfamide—Paraesthesia—Capecitabine—prostate cancer	8.78e-06	0.000144	CcSEcCtD
Ifosfamide—Decreased appetite—Docetaxel—prostate cancer	8.78e-06	0.000144	CcSEcCtD
Ifosfamide—Urinary tract disorder—Doxorubicin—prostate cancer	8.76e-06	0.000144	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Docetaxel—prostate cancer	8.72e-06	0.000143	CcSEcCtD
Ifosfamide—Asthenia—Etoposide—prostate cancer	8.72e-06	0.000143	CcSEcCtD
Ifosfamide—Connective tissue disorder—Doxorubicin—prostate cancer	8.72e-06	0.000143	CcSEcCtD
Ifosfamide—Dyspnoea—Capecitabine—prostate cancer	8.72e-06	0.000143	CcSEcCtD
Ifosfamide—Anaphylactic shock—Prednisone—prostate cancer	8.71e-06	0.000143	CcSEcCtD
Ifosfamide—Oedema—Prednisone—prostate cancer	8.71e-06	0.000143	CcSEcCtD
Ifosfamide—Fatigue—Docetaxel—prostate cancer	8.71e-06	0.000143	CcSEcCtD
Ifosfamide—Angiopathy—Epirubicin—prostate cancer	8.7e-06	0.000143	CcSEcCtD
Ifosfamide—Urethral disorder—Doxorubicin—prostate cancer	8.69e-06	0.000143	CcSEcCtD
Ifosfamide—Nausea—Mitoxantrone—prostate cancer	8.68e-06	0.000142	CcSEcCtD
Ifosfamide—Immune system disorder—Epirubicin—prostate cancer	8.66e-06	0.000142	CcSEcCtD
Ifosfamide—Infection—Prednisone—prostate cancer	8.65e-06	0.000142	CcSEcCtD
Ifosfamide—Mediastinal disorder—Epirubicin—prostate cancer	8.64e-06	0.000142	CcSEcCtD
Ifosfamide—Pain—Docetaxel—prostate cancer	8.63e-06	0.000142	CcSEcCtD
Ifosfamide—Constipation—Docetaxel—prostate cancer	8.63e-06	0.000142	CcSEcCtD
Ifosfamide—Chills—Epirubicin—prostate cancer	8.6e-06	0.000141	CcSEcCtD
Ifosfamide—Pruritus—Etoposide—prostate cancer	8.6e-06	0.000141	CcSEcCtD
Ifosfamide—Arrhythmia—Epirubicin—prostate cancer	8.56e-06	0.000141	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—prostate cancer	8.55e-06	0.00014	CcSEcCtD
Ifosfamide—Nervous system disorder—Prednisone—prostate cancer	8.54e-06	0.00014	CcSEcCtD
Ifosfamide—Decreased appetite—Capecitabine—prostate cancer	8.5e-06	0.000139	CcSEcCtD
Ifosfamide—Alopecia—Epirubicin—prostate cancer	8.47e-06	0.000139	CcSEcCtD
Ifosfamide—Skin disorder—Prednisone—prostate cancer	8.46e-06	0.000139	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Capecitabine—prostate cancer	8.44e-06	0.000139	CcSEcCtD
Ifosfamide—Fatigue—Capecitabine—prostate cancer	8.43e-06	0.000138	CcSEcCtD
Ifosfamide—Hyperhidrosis—Prednisone—prostate cancer	8.42e-06	0.000138	CcSEcCtD
Ifosfamide—Mental disorder—Epirubicin—prostate cancer	8.4e-06	0.000138	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—prostate cancer	8.39e-06	0.000138	CcSEcCtD
Ifosfamide—Pain—Capecitabine—prostate cancer	8.36e-06	0.000137	CcSEcCtD
Ifosfamide—Constipation—Capecitabine—prostate cancer	8.36e-06	0.000137	CcSEcCtD
Ifosfamide—Malnutrition—Epirubicin—prostate cancer	8.34e-06	0.000137	CcSEcCtD
Ifosfamide—Erythema—Epirubicin—prostate cancer	8.34e-06	0.000137	CcSEcCtD
Ifosfamide—Feeling abnormal—Docetaxel—prostate cancer	8.32e-06	0.000137	CcSEcCtD
Ifosfamide—Diarrhoea—Etoposide—prostate cancer	8.31e-06	0.000136	CcSEcCtD
Ifosfamide—Anorexia—Prednisone—prostate cancer	8.3e-06	0.000136	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—prostate cancer	8.29e-06	0.000136	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—prostate cancer	8.27e-06	0.000136	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Docetaxel—prostate cancer	8.26e-06	0.000136	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—prostate cancer	8.23e-06	0.000135	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—prostate cancer	8.23e-06	0.000135	CcSEcCtD
Ifosfamide—Feeling abnormal—Capecitabine—prostate cancer	8.06e-06	0.000132	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—prostate cancer	8.05e-06	0.000132	CcSEcCtD
Ifosfamide—Dizziness—Etoposide—prostate cancer	8.03e-06	0.000132	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—prostate cancer	8.01e-06	0.000132	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Capecitabine—prostate cancer	7.99e-06	0.000131	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—prostate cancer	7.99e-06	0.000131	CcSEcCtD
Ifosfamide—Abdominal pain—Docetaxel—prostate cancer	7.98e-06	0.000131	CcSEcCtD
Ifosfamide—Body temperature increased—Docetaxel—prostate cancer	7.98e-06	0.000131	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—prostate cancer	7.96e-06	0.000131	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Prednisone—prostate cancer	7.93e-06	0.00013	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—prostate cancer	7.92e-06	0.00013	CcSEcCtD
Ifosfamide—Vision blurred—Epirubicin—prostate cancer	7.86e-06	0.000129	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—prostate cancer	7.84e-06	0.000129	CcSEcCtD
Ifosfamide—Paraesthesia—Prednisone—prostate cancer	7.82e-06	0.000128	CcSEcCtD
Ifosfamide—Mental disorder—Doxorubicin—prostate cancer	7.77e-06	0.000128	CcSEcCtD
Ifosfamide—Urticaria—Capecitabine—prostate cancer	7.77e-06	0.000127	CcSEcCtD
Ifosfamide—Ill-defined disorder—Epirubicin—prostate cancer	7.74e-06	0.000127	CcSEcCtD
Ifosfamide—Body temperature increased—Capecitabine—prostate cancer	7.73e-06	0.000127	CcSEcCtD
Ifosfamide—Abdominal pain—Capecitabine—prostate cancer	7.73e-06	0.000127	CcSEcCtD
Ifosfamide—Vomiting—Etoposide—prostate cancer	7.73e-06	0.000127	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—prostate cancer	7.72e-06	0.000127	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—prostate cancer	7.72e-06	0.000127	CcSEcCtD
Ifosfamide—Anaemia—Epirubicin—prostate cancer	7.71e-06	0.000127	CcSEcCtD
Ifosfamide—Agitation—Epirubicin—prostate cancer	7.67e-06	0.000126	CcSEcCtD
Ifosfamide—Rash—Etoposide—prostate cancer	7.66e-06	0.000126	CcSEcCtD
Ifosfamide—Dermatitis—Etoposide—prostate cancer	7.65e-06	0.000126	CcSEcCtD
Ifosfamide—Decreased appetite—Prednisone—prostate cancer	7.57e-06	0.000124	CcSEcCtD
Ifosfamide—Malaise—Epirubicin—prostate cancer	7.53e-06	0.000124	CcSEcCtD
Ifosfamide—Fatigue—Prednisone—prostate cancer	7.51e-06	0.000123	CcSEcCtD
Ifosfamide—Vertigo—Epirubicin—prostate cancer	7.5e-06	0.000123	CcSEcCtD
Ifosfamide—Leukopenia—Epirubicin—prostate cancer	7.47e-06	0.000123	CcSEcCtD
Ifosfamide—Constipation—Prednisone—prostate cancer	7.45e-06	0.000122	CcSEcCtD
Ifosfamide—Hypersensitivity—Docetaxel—prostate cancer	7.44e-06	0.000122	CcSEcCtD
Ifosfamide—Palpitations—Epirubicin—prostate cancer	7.37e-06	0.000121	CcSEcCtD
Ifosfamide—Cough—Epirubicin—prostate cancer	7.28e-06	0.00012	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—prostate cancer	7.28e-06	0.000119	CcSEcCtD
Ifosfamide—Asthenia—Docetaxel—prostate cancer	7.24e-06	0.000119	CcSEcCtD
Ifosfamide—Convulsion—Epirubicin—prostate cancer	7.23e-06	0.000119	CcSEcCtD
Ifosfamide—Nausea—Etoposide—prostate cancer	7.22e-06	0.000118	CcSEcCtD
Ifosfamide—Hypertension—Epirubicin—prostate cancer	7.2e-06	0.000118	CcSEcCtD
Ifosfamide—Hypersensitivity—Capecitabine—prostate cancer	7.2e-06	0.000118	CcSEcCtD
Ifosfamide—Feeling abnormal—Prednisone—prostate cancer	7.18e-06	0.000118	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—prostate cancer	7.16e-06	0.000118	CcSEcCtD
Ifosfamide—Pruritus—Docetaxel—prostate cancer	7.14e-06	0.000117	CcSEcCtD
Ifosfamide—Anaemia—Doxorubicin—prostate cancer	7.14e-06	0.000117	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Prednisone—prostate cancer	7.12e-06	0.000117	CcSEcCtD
Ifosfamide—Chest pain—Epirubicin—prostate cancer	7.1e-06	0.000117	CcSEcCtD
Ifosfamide—Myalgia—Epirubicin—prostate cancer	7.1e-06	0.000117	CcSEcCtD
Ifosfamide—Arthralgia—Epirubicin—prostate cancer	7.1e-06	0.000117	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—prostate cancer	7.1e-06	0.000116	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	7.06e-06	0.000116	CcSEcCtD
Ifosfamide—Discomfort—Epirubicin—prostate cancer	7.02e-06	0.000115	CcSEcCtD
Ifosfamide—Asthenia—Capecitabine—prostate cancer	7.01e-06	0.000115	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—prostate cancer	6.96e-06	0.000114	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—prostate cancer	6.94e-06	0.000114	CcSEcCtD
Ifosfamide—Urticaria—Prednisone—prostate cancer	6.92e-06	0.000114	CcSEcCtD
Ifosfamide—Pruritus—Capecitabine—prostate cancer	6.92e-06	0.000114	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—prostate cancer	6.91e-06	0.000113	CcSEcCtD
Ifosfamide—Diarrhoea—Docetaxel—prostate cancer	6.91e-06	0.000113	CcSEcCtD
Ifosfamide—Body temperature increased—Prednisone—prostate cancer	6.88e-06	0.000113	CcSEcCtD
Ifosfamide—Abdominal pain—Prednisone—prostate cancer	6.88e-06	0.000113	CcSEcCtD
Ifosfamide—Confusional state—Epirubicin—prostate cancer	6.87e-06	0.000113	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—prostate cancer	6.82e-06	0.000112	CcSEcCtD
Ifosfamide—Anaphylactic shock—Epirubicin—prostate cancer	6.81e-06	0.000112	CcSEcCtD
Ifosfamide—Oedema—Epirubicin—prostate cancer	6.81e-06	0.000112	CcSEcCtD
Ifosfamide—Infection—Epirubicin—prostate cancer	6.77e-06	0.000111	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—prostate cancer	6.74e-06	0.000111	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—prostate cancer	6.69e-06	0.00011	CcSEcCtD
Ifosfamide—Diarrhoea—Capecitabine—prostate cancer	6.69e-06	0.00011	CcSEcCtD
Ifosfamide—Nervous system disorder—Epirubicin—prostate cancer	6.68e-06	0.00011	CcSEcCtD
Ifosfamide—Dizziness—Docetaxel—prostate cancer	6.68e-06	0.00011	CcSEcCtD
Ifosfamide—Thrombocytopenia—Epirubicin—prostate cancer	6.67e-06	0.000109	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—prostate cancer	6.67e-06	0.000109	CcSEcCtD
Ifosfamide—Skin disorder—Epirubicin—prostate cancer	6.62e-06	0.000109	CcSEcCtD
Ifosfamide—Hyperhidrosis—Epirubicin—prostate cancer	6.58e-06	0.000108	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—prostate cancer	6.57e-06	0.000108	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—prostate cancer	6.57e-06	0.000108	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—prostate cancer	6.57e-06	0.000108	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.53e-06	0.000107	CcSEcCtD
Ifosfamide—Discomfort—Doxorubicin—prostate cancer	6.49e-06	0.000107	CcSEcCtD
Ifosfamide—Anorexia—Epirubicin—prostate cancer	6.49e-06	0.000107	CcSEcCtD
Ifosfamide—Dizziness—Capecitabine—prostate cancer	6.46e-06	0.000106	CcSEcCtD
Ifosfamide—Vomiting—Docetaxel—prostate cancer	6.42e-06	0.000105	CcSEcCtD
Ifosfamide—Hypersensitivity—Prednisone—prostate cancer	6.42e-06	0.000105	CcSEcCtD
Ifosfamide—Rash—Docetaxel—prostate cancer	6.37e-06	0.000104	CcSEcCtD
Ifosfamide—Hypotension—Epirubicin—prostate cancer	6.36e-06	0.000104	CcSEcCtD
Ifosfamide—Dermatitis—Docetaxel—prostate cancer	6.36e-06	0.000104	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—prostate cancer	6.35e-06	0.000104	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—prostate cancer	6.3e-06	0.000103	CcSEcCtD
Ifosfamide—Oedema—Doxorubicin—prostate cancer	6.3e-06	0.000103	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—prostate cancer	6.26e-06	0.000103	CcSEcCtD
Ifosfamide—Asthenia—Prednisone—prostate cancer	6.25e-06	0.000103	CcSEcCtD
Ifosfamide—Vomiting—Capecitabine—prostate cancer	6.22e-06	0.000102	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.2e-06	0.000102	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—prostate cancer	6.18e-06	0.000101	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—prostate cancer	6.17e-06	0.000101	CcSEcCtD
Ifosfamide—Rash—Capecitabine—prostate cancer	6.16e-06	0.000101	CcSEcCtD
Ifosfamide—Pruritus—Prednisone—prostate cancer	6.16e-06	0.000101	CcSEcCtD
Ifosfamide—Dermatitis—Capecitabine—prostate cancer	6.16e-06	0.000101	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—prostate cancer	6.12e-06	0.0001	CcSEcCtD
Ifosfamide—Paraesthesia—Epirubicin—prostate cancer	6.12e-06	0.0001	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—prostate cancer	6.09e-06	0.0001	CcSEcCtD
Ifosfamide—Dyspnoea—Epirubicin—prostate cancer	6.07e-06	9.97e-05	CcSEcCtD
Ifosfamide—Somnolence—Epirubicin—prostate cancer	6.05e-06	9.94e-05	CcSEcCtD
Ifosfamide—Anorexia—Doxorubicin—prostate cancer	6.01e-06	9.86e-05	CcSEcCtD
Ifosfamide—Nausea—Docetaxel—prostate cancer	6e-06	9.84e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Prednisone—prostate cancer	5.96e-06	9.78e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Epirubicin—prostate cancer	5.92e-06	9.72e-05	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—prostate cancer	5.89e-06	9.67e-05	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Epirubicin—prostate cancer	5.88e-06	9.65e-05	CcSEcCtD
Ifosfamide—Fatigue—Epirubicin—prostate cancer	5.87e-06	9.64e-05	CcSEcCtD
Ifosfamide—Pain—Epirubicin—prostate cancer	5.82e-06	9.56e-05	CcSEcCtD
Ifosfamide—Constipation—Epirubicin—prostate cancer	5.82e-06	9.56e-05	CcSEcCtD
Ifosfamide—Nausea—Capecitabine—prostate cancer	5.81e-06	9.53e-05	CcSEcCtD
Ifosfamide—Dizziness—Prednisone—prostate cancer	5.76e-06	9.45e-05	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.74e-06	9.42e-05	CcSEcCtD
Ifosfamide—Paraesthesia—Doxorubicin—prostate cancer	5.66e-06	9.29e-05	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—prostate cancer	5.62e-06	9.22e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Epirubicin—prostate cancer	5.61e-06	9.21e-05	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—prostate cancer	5.6e-06	9.2e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Epirubicin—prostate cancer	5.57e-06	9.14e-05	CcSEcCtD
Ifosfamide—Vomiting—Prednisone—prostate cancer	5.54e-06	9.09e-05	CcSEcCtD
Ifosfamide—Rash—Prednisone—prostate cancer	5.49e-06	9.01e-05	CcSEcCtD
Ifosfamide—Dermatitis—Prednisone—prostate cancer	5.49e-06	9e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Doxorubicin—prostate cancer	5.48e-06	8.99e-05	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.44e-06	8.93e-05	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—prostate cancer	5.43e-06	8.92e-05	CcSEcCtD
Ifosfamide—Urticaria—Epirubicin—prostate cancer	5.41e-06	8.88e-05	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—prostate cancer	5.39e-06	8.85e-05	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—prostate cancer	5.39e-06	8.85e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Epirubicin—prostate cancer	5.38e-06	8.84e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Epirubicin—prostate cancer	5.38e-06	8.84e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Doxorubicin—prostate cancer	5.19e-06	8.52e-05	CcSEcCtD
Ifosfamide—Nausea—Prednisone—prostate cancer	5.17e-06	8.49e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Doxorubicin—prostate cancer	5.15e-06	8.46e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Epirubicin—prostate cancer	5.02e-06	8.24e-05	CcSEcCtD
Ifosfamide—Urticaria—Doxorubicin—prostate cancer	5.01e-06	8.22e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—prostate cancer	4.98e-06	8.18e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Doxorubicin—prostate cancer	4.98e-06	8.18e-05	CcSEcCtD
Ifosfamide—Asthenia—Epirubicin—prostate cancer	4.89e-06	8.02e-05	CcSEcCtD
Ifosfamide—Pruritus—Epirubicin—prostate cancer	4.82e-06	7.91e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Epirubicin—prostate cancer	4.66e-06	7.65e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—prostate cancer	4.64e-06	7.62e-05	CcSEcCtD
Ifosfamide—Asthenia—Doxorubicin—prostate cancer	4.52e-06	7.42e-05	CcSEcCtD
Ifosfamide—Dizziness—Epirubicin—prostate cancer	4.5e-06	7.39e-05	CcSEcCtD
Ifosfamide—Pruritus—Doxorubicin—prostate cancer	4.46e-06	7.32e-05	CcSEcCtD
Ifosfamide—Vomiting—Epirubicin—prostate cancer	4.33e-06	7.11e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Doxorubicin—prostate cancer	4.31e-06	7.08e-05	CcSEcCtD
Ifosfamide—Rash—Epirubicin—prostate cancer	4.29e-06	7.05e-05	CcSEcCtD
Ifosfamide—Dermatitis—Epirubicin—prostate cancer	4.29e-06	7.04e-05	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—prostate cancer	4.17e-06	6.84e-05	CcSEcCtD
Ifosfamide—Nausea—Epirubicin—prostate cancer	4.05e-06	6.64e-05	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—prostate cancer	4.01e-06	6.58e-05	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—prostate cancer	3.97e-06	6.52e-05	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—prostate cancer	3.97e-06	6.52e-05	CcSEcCtD
Ifosfamide—Nausea—Doxorubicin—prostate cancer	3.74e-06	6.14e-05	CcSEcCtD
Ifosfamide—PTGS1—Metabolism—CAV1—prostate cancer	9.95e-07	2.61e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	9.92e-07	2.6e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTP1—prostate cancer	9.91e-07	2.6e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1B1—prostate cancer	9.87e-07	2.59e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ITPR1—prostate cancer	9.75e-07	2.56e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKR1C3—prostate cancer	9.69e-07	2.54e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PRKACB—prostate cancer	9.64e-07	2.53e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HSD3B1—prostate cancer	9.62e-07	2.52e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC22A3—prostate cancer	9.62e-07	2.52e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GGT1—prostate cancer	9.56e-07	2.5e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP17A1—prostate cancer	9.54e-07	2.5e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SLC5A5—prostate cancer	9.51e-07	2.49e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.51e-07	2.49e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—TYMS—prostate cancer	9.43e-07	2.47e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CAV1—prostate cancer	9.41e-07	2.47e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NCOA1—prostate cancer	9.41e-07	2.47e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.41e-07	2.47e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CG—prostate cancer	9.35e-07	2.45e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTM1—prostate cancer	9.32e-07	2.44e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTEN—prostate cancer	9.32e-07	2.44e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP2E1—prostate cancer	9.29e-07	2.44e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP19A1—prostate cancer	9.28e-07	2.43e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA4—prostate cancer	9.22e-07	2.42e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TBXAS1—prostate cancer	9.22e-07	2.42e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—TYMS—prostate cancer	9.21e-07	2.41e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NQO1—prostate cancer	9.19e-07	2.41e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—LPL—prostate cancer	9.15e-07	2.4e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTM1—prostate cancer	9.11e-07	2.39e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NCOA2—prostate cancer	9.09e-07	2.38e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CG—prostate cancer	9.07e-07	2.38e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—TH—prostate cancer	9.05e-07	2.37e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.99e-07	2.36e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA2—prostate cancer	8.99e-07	2.36e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP3A4—prostate cancer	8.96e-07	2.35e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—RXRA—prostate cancer	8.95e-07	2.35e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—LPL—prostate cancer	8.94e-07	2.34e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.91e-07	2.34e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—EP300—prostate cancer	8.89e-07	2.33e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.88e-07	2.33e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCG5—prostate cancer	8.88e-07	2.33e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—INS—prostate cancer	8.85e-07	2.32e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP1A1—prostate cancer	8.83e-07	2.32e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1B1—prostate cancer	8.81e-07	2.31e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ERCC2—prostate cancer	8.76e-07	2.3e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.71e-07	2.28e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CREBBP—prostate cancer	8.67e-07	2.27e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC5A5—prostate cancer	8.67e-07	2.27e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA1—prostate cancer	8.67e-07	2.27e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP1A1—prostate cancer	8.63e-07	2.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—COMT—prostate cancer	8.62e-07	2.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTP1—prostate cancer	8.58e-07	2.25e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—INS—prostate cancer	8.58e-07	2.25e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CG—prostate cancer	8.57e-07	2.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTO1—prostate cancer	8.57e-07	2.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HSD3B2—prostate cancer	8.57e-07	2.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NAT2—prostate cancer	8.57e-07	2.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ERCC2—prostate cancer	8.56e-07	2.24e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GGT1—prostate cancer	8.53e-07	2.24e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP2E1—prostate cancer	8.47e-07	2.22e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ITPR1—prostate cancer	8.45e-07	2.21e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CREBBP—prostate cancer	8.41e-07	2.2e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NCOA1—prostate cancer	8.4e-07	2.2e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NQO1—prostate cancer	8.38e-07	2.2e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.3e-07	2.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP19A1—prostate cancer	8.28e-07	2.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—TH—prostate cancer	8.25e-07	2.16e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—MTHFR—prostate cancer	8.23e-07	2.16e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CD—prostate cancer	8.22e-07	2.16e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PLCB2—prostate cancer	8.22e-07	2.15e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2C18—prostate cancer	8.22e-07	2.15e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LRP2—prostate cancer	8.22e-07	2.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.2e-07	2.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP3A4—prostate cancer	8.17e-07	2.14e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.13e-07	2.13e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—INS—prostate cancer	8.12e-07	2.13e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARA—prostate cancer	8.08e-07	2.12e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—P4HB—prostate cancer	8.06e-07	2.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—MTHFR—prostate cancer	8.05e-07	2.11e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1B1—prostate cancer	8.03e-07	2.1e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—RXRA—prostate cancer	7.99e-07	2.09e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—TYMS—prostate cancer	7.98e-07	2.09e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CD—prostate cancer	7.97e-07	2.09e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CREBBP—prostate cancer	7.95e-07	2.08e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARA—prostate cancer	7.9e-07	2.07e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTM1—prostate cancer	7.89e-07	2.07e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.84e-07	2.06e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GGT1—prostate cancer	7.78e-07	2.04e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.77e-07	2.04e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NOS3—prostate cancer	7.77e-07	2.04e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—LPL—prostate cancer	7.74e-07	2.03e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—COMT—prostate cancer	7.7e-07	2.02e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTP1—prostate cancer	7.66e-07	2.01e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NCOA1—prostate cancer	7.66e-07	2.01e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.64e-07	2e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CAV1—prostate cancer	7.59e-07	1.99e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP19A1—prostate cancer	7.55e-07	1.98e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ITPR1—prostate cancer	7.54e-07	1.98e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CD—prostate cancer	7.54e-07	1.98e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NOS3—prostate cancer	7.53e-07	1.97e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MED12—prostate cancer	7.52e-07	1.97e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1A1—prostate cancer	7.48e-07	1.96e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GNG5—prostate cancer	7.46e-07	1.95e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CAV1—prostate cancer	7.42e-07	1.95e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ERCC2—prostate cancer	7.42e-07	1.94e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.41e-07	1.94e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—RXRA—prostate cancer	7.29e-07	1.91e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NCOA3—prostate cancer	7.18e-07	1.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CB—prostate cancer	7.17e-07	1.88e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—TYMS—prostate cancer	7.12e-07	1.87e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NOS3—prostate cancer	7.12e-07	1.87e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—prostate cancer	7.1e-07	1.86e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.09e-07	1.86e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTM1—prostate cancer	7.04e-07	1.85e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—COMT—prostate cancer	7.02e-07	1.84e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTP1—prostate cancer	6.99e-07	1.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—MTHFR—prostate cancer	6.97e-07	1.83e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CB—prostate cancer	6.95e-07	1.82e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CG—prostate cancer	6.92e-07	1.81e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—LPL—prostate cancer	6.91e-07	1.81e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—prostate cancer	6.88e-07	1.8e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ITPR1—prostate cancer	6.87e-07	1.8e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HPGDS—prostate cancer	6.85e-07	1.8e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARA—prostate cancer	6.84e-07	1.79e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.81e-07	1.79e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CG—prostate cancer	6.76e-07	1.77e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.76e-07	1.77e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1A1—prostate cancer	6.67e-07	1.75e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ACHE—prostate cancer	6.65e-07	1.74e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTT1—prostate cancer	6.65e-07	1.74e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ERCC2—prostate cancer	6.62e-07	1.74e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—prostate cancer	6.57e-07	1.72e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.57e-07	1.72e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CB—prostate cancer	6.57e-07	1.72e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—INS—prostate cancer	6.55e-07	1.72e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—prostate cancer	6.51e-07	1.71e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—TYMS—prostate cancer	6.49e-07	1.7e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CAV1—prostate cancer	6.43e-07	1.69e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTM1—prostate cancer	6.42e-07	1.68e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CREBBP—prostate cancer	6.41e-07	1.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—INS—prostate cancer	6.4e-07	1.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.39e-07	1.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PRKACB—prostate cancer	6.36e-07	1.67e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—LPL—prostate cancer	6.3e-07	1.65e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.29e-07	1.65e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CREBBP—prostate cancer	6.27e-07	1.64e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—MTHFR—prostate cancer	6.22e-07	1.63e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTEN—prostate cancer	6.19e-07	1.62e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.14e-07	1.61e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARA—prostate cancer	6.1e-07	1.6e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1A1—prostate cancer	6.09e-07	1.6e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CD—prostate cancer	6.08e-07	1.59e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ERCC2—prostate cancer	6.04e-07	1.58e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTEN—prostate cancer	6e-07	1.57e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NCOA2—prostate cancer	6e-07	1.57e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CD—prostate cancer	5.94e-07	1.56e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—EP300—prostate cancer	5.91e-07	1.55e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CG—prostate cancer	5.86e-07	1.54e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NOS3—prostate cancer	5.74e-07	1.51e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CAV1—prostate cancer	5.74e-07	1.5e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—EP300—prostate cancer	5.73e-07	1.5e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.72e-07	1.5e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTEN—prostate cancer	5.68e-07	1.49e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—MTHFR—prostate cancer	5.67e-07	1.49e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NOS3—prostate cancer	5.61e-07	1.47e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.59e-07	1.46e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARA—prostate cancer	5.57e-07	1.46e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—INS—prostate cancer	5.54e-07	1.45e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NQO1—prostate cancer	5.52e-07	1.45e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.48e-07	1.44e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TH—prostate cancer	5.44e-07	1.43e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CREBBP—prostate cancer	5.43e-07	1.42e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—EP300—prostate cancer	5.41e-07	1.42e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—prostate cancer	5.37e-07	1.41e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CB—prostate cancer	5.3e-07	1.39e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.3e-07	1.39e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—prostate cancer	5.25e-07	1.38e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CAV1—prostate cancer	5.23e-07	1.37e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CG—prostate cancer	5.23e-07	1.37e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CB—prostate cancer	5.18e-07	1.36e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CD—prostate cancer	5.15e-07	1.35e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—prostate cancer	5.13e-07	1.35e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GGT1—prostate cancer	5.13e-07	1.34e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NCOA1—prostate cancer	5.05e-07	1.32e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5e-07	1.31e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.98e-07	1.31e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—INS—prostate cancer	4.95e-07	1.3e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NOS3—prostate cancer	4.86e-07	1.27e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CREBBP—prostate cancer	4.85e-07	1.27e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—RXRA—prostate cancer	4.81e-07	1.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CG—prostate cancer	4.77e-07	1.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—COMT—prostate cancer	4.63e-07	1.21e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTP1—prostate cancer	4.61e-07	1.21e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CD—prostate cancer	4.6e-07	1.2e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTEN—prostate cancer	4.58e-07	1.2e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ITPR1—prostate cancer	4.53e-07	1.19e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—INS—prostate cancer	4.51e-07	1.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CB—prostate cancer	4.49e-07	1.18e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTEN—prostate cancer	4.48e-07	1.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—prostate cancer	4.45e-07	1.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CREBBP—prostate cancer	4.42e-07	1.16e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—prostate cancer	4.37e-07	1.15e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—EP300—prostate cancer	4.37e-07	1.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NOS3—prostate cancer	4.34e-07	1.14e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TYMS—prostate cancer	4.28e-07	1.12e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—EP300—prostate cancer	4.27e-07	1.12e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—prostate cancer	4.24e-07	1.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTM1—prostate cancer	4.23e-07	1.11e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CD—prostate cancer	4.19e-07	1.1e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LPL—prostate cancer	4.16e-07	1.09e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.01e-07	1.05e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CB—prostate cancer	4.01e-07	1.05e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—prostate cancer	4.01e-07	1.05e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ERCC2—prostate cancer	3.98e-07	1.04e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—prostate cancer	3.97e-07	1.04e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NOS3—prostate cancer	3.96e-07	1.04e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTEN—prostate cancer	3.88e-07	1.02e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTHFR—prostate cancer	3.74e-07	9.81e-06	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—EP300—prostate cancer	3.7e-07	9.69e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARA—prostate cancer	3.67e-07	9.62e-06	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CB—prostate cancer	3.65e-07	9.57e-06	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—prostate cancer	3.62e-07	9.49e-06	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—prostate cancer	3.57e-07	9.36e-06	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTEN—prostate cancer	3.46e-07	9.07e-06	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—prostate cancer	3.46e-07	9.07e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CAV1—prostate cancer	3.45e-07	9.05e-06	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—EP300—prostate cancer	3.3e-07	8.65e-06	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—prostate cancer	3.27e-07	8.58e-06	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—prostate cancer	3.23e-07	8.47e-06	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—prostate cancer	3.16e-07	8.28e-06	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTEN—prostate cancer	3.16e-07	8.27e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.14e-07	8.24e-06	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—EP300—prostate cancer	3.01e-07	7.89e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—INS—prostate cancer	2.98e-07	7.8e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CREBBP—prostate cancer	2.91e-07	7.64e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.76e-07	7.24e-06	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—prostate cancer	2.74e-07	7.17e-06	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—prostate cancer	2.64e-07	6.92e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NOS3—prostate cancer	2.61e-07	6.84e-06	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—prostate cancer	2.58e-07	6.76e-06	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—prostate cancer	2.44e-07	6.4e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.41e-07	6.31e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—prostate cancer	2.39e-07	6.26e-06	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—prostate cancer	2.23e-07	5.86e-06	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.23e-07	5.84e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTEN—prostate cancer	2.08e-07	5.46e-06	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—prostate cancer	1.99e-07	5.23e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—EP300—prostate cancer	1.99e-07	5.2e-06	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—prostate cancer	1.82e-07	4.77e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.47e-07	3.85e-06	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—prostate cancer	1.2e-07	3.14e-06	CbGpPWpGaD
